| [Pharmaceutical intermediates] |
 |
| We presently produce about 50 types of pharmaceutical intermediates and are widely involved from basic raw materials to crucial intermediates. To enable our customers to fully entrust us with production, Manac willingly accepts user inspections and substantiates both hardware and software aspects of production. |
 |
| [Bulk drug substance] |
 |
| For inorganic pharmaceuticals and organic pharmaceuticals that have been approved for production on our own and by commission, we pursue pharmaceutical production systems that are optimized according to each product and make further efforts toward more advanced quality control and improved productivity. We can answer needs for commissioned production of both existing products and new products. |
 |
| [Bulk drug substance for clinical trials] |
 |
| With the implementation of GCP ordinances, GMP for clinical trial pharmaceuticals has become essential. We at Manac make use of our know-how cultivated through the production of pharmaceutical intermediates and bulk pharmaceuticals to proactively meet needs for trial production and production of bulk pharmaceuticals for clinical trials. |